|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Gross premiums written | |||||
| Gross premiums ceded | |||||
| Net premiums written | |||||
| Change in net unearned premium reserves | |||||
| Net premiums earned | |||||
| Income from investment in related party investment fund (see Note $3 ) | |||||
| Net investment income | |||||
| Foreign exchange gains (losses) | |||||
| Other income | |||||
| Total revenues | |||||
| Expenses | |||||
| Net loss and loss adjustment expenses incurred | |||||
| Acquisition costs | |||||
| General and administrative expenses | |||||
| Underwriting expenses | |||||
| Corporate and other expenses | |||||
| Total general and administrative expenses | |||||
| Deposit interest expense | |||||
| Interest expense | |||||
| Total expenses | |||||
| Income before income tax | |||||
| Income tax expense | |||||
| Net income | |||||
| Earnings per share ("EPS"): | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Weighted average number of ordinary shares used in the determination of EPS: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
Loading...